Kristen Rothe - CareCloud Corporate Officer
| CCLD Stock | 2.32 0.04 1.69% |
Executive
Kristen Rothe is Corporate Officer of CareCloud
| Address | 7 Clyde Road, Somerset, NJ, United States, 08873 |
| Phone | 732 873 5133 |
| Web | https://www.carecloud.com |
CareCloud Management Efficiency
The company has return on total asset (ROA) of 0.0924 % which means that it generated a profit of $0.0924 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2149 %, meaning that it created $0.2149 on every $100 dollars invested by stockholders. CareCloud's management efficiency ratios could be used to measure how well CareCloud manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.28. The current year's Return On Capital Employed is expected to grow to 0.21. At present, CareCloud's Net Tangible Assets are projected to decrease significantly based on the last few years of reporting. The current year's Return On Tangible Assets is expected to grow to 0.28, whereas Non Current Assets Total are forecasted to decline to about 41.3 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| John Ballard | Vivos Therapeutics | N/A | |
| Joyce Johnson | Allurion Technologies | N/A | |
| Dan CPA | Co Diagnostics | N/A | |
| Terry Jones | Vivos Therapeutics | N/A | |
| Tim Glynn | Adagio Medical Holdings | N/A | |
| Alexandra Stap | Allurion Technologies | N/A | |
| Nabil Jubran | Adagio Medical Holdings | N/A | |
| Adrian Wild | Allurion Technologies | N/A | |
| Gerwin Westfield | Aytu BioScience | N/A | |
| Steven CPA | ProPhase Labs | 65 | |
| Ivory Chang | Co Diagnostics | N/A | |
| John Niles | GeoVax Labs | N/A | |
| Kamal Obbad | ProPhase Labs | N/A | |
| Jason Jones | Ekso Bionics Holdings | N/A | |
| Ryan CPA | Aytu BioScience | 44 | |
| Stephanie Huebner | Vivos Therapeutics | N/A | |
| Michael Bruhn | Vivos Therapeutics | N/A | |
| Lance Bisesar | ProPhase Labs | N/A | |
| David Nielsen | Co Diagnostics | N/A | |
| Robert Morse | ProPhase Labs | 49 | |
| Matt Wright | Allurion Technologies | N/A | |
Management Performance
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.0924 |
CareCloud Leadership Team
Elected by the shareholders, the CareCloud's board of directors comprises two types of representatives: CareCloud inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CareCloud. The board's role is to monitor CareCloud's management team and ensure that shareholders' interests are well served. CareCloud's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CareCloud's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nathalie Garcia, Chief Counsel | ||
| Christopher Langehaug, Senior Growth | ||
| Kimberly Esq, VP Counsel | ||
| Kaitlyn Mode, Corporate Manager | ||
| Mike Cuesta, Chief Officer | ||
| Kristen Rothe, Corporate Officer | ||
| Adeel Sarwar, Chief Officer | ||
| Cody Frew, Vice Marketing | ||
| Karl Johnson, Senior Development | ||
| Stephen JD, CoChief Officer | ||
| Loraine Goetsch, Division Integrations | ||
| Hadi Chaudhry, CoCEO Director | ||
| Steve Link, Chief Officer | ||
| Elizabeth Ferrer, Vice Resources | ||
| Ryan Howard, Special Officer | ||
| Alejandra Rodriguez, Corporate Officer | ||
| Norman Roth, CFO, Secretary | ||
| Chantelle Melendez, Corporate Counsel | ||
| Ali Shaukat, Managing Operations | ||
| Stephen Snyder, President | ||
| Justin Pierce, Chief Officer | ||
| Mahmud Haq, Founder Chairman | ||
| Alfonso Nardi, Senior Officer | ||
| Crystal Williams, Chief Officer |
CareCloud Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CareCloud a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.0924 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 103.98 M | ||||
| Shares Outstanding | 42.4 M | ||||
| Shares Owned By Insiders | 15.15 % | ||||
| Shares Owned By Institutions | 26.66 % | ||||
| Number Of Shares Shorted | 522.05 K | ||||
| Price To Book | 1.71 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether CareCloud offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of CareCloud's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Carecloud Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Carecloud Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CareCloud. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade CareCloud Stock refer to our How to Trade CareCloud Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Will Health Care Equipment & Supplies sector continue expanding? Could CareCloud diversify its offerings? Factors like these will boost the valuation of CareCloud. Projected growth potential of CareCloud fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CareCloud data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.07 | Revenue Per Share | Quarterly Revenue Growth 0.088 | Return On Assets | Return On Equity |
The market value of CareCloud is measured differently than its book value, which is the value of CareCloud that is recorded on the company's balance sheet. Investors also form their own opinion of CareCloud's value that differs from its market value or its book value, called intrinsic value, which is CareCloud's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because CareCloud's market value can be influenced by many factors that don't directly affect CareCloud's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between CareCloud's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CareCloud should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, CareCloud's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.